SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M E Schutzer, P F Orio, M C Biagioli, D A Asher, H Lomas, D Moghanaki, A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers, Prostate Cancer and Prostatic Disease, 2015,

    CrossRef

  2. 2
    Yong Hyun Park, In Young Choi, Sei Chul Yoon, Hong Seok Jang, Hyong Woo Moon, Sung-Hoo Hong, Sae Woong Kim, Tae-Kon Hwang, Ji Youl Lee, Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer, Prostate International, 2015,

    CrossRef

  3. 3
    Won Park, Radiotherapy for prostate cancer, Journal of the Korean Medical Association, 2015, 58, 1, 21

    CrossRef

  4. 4
    Stefania Clemente, Roberta Nigro, Caterina Oliviero, Chiara Marchioni, Marco Esposito, Francesca Romana Giglioli, Pietro Mancosu, Carmelo Marino, Serenella Russo, Michele Stasi, Lidia Strigari, Ivan Veronese, Valeria Landoni, Role of the Technical Aspects of Hypofractionated Radiation Therapy Treatment of Prostate Cancer: A Review, International Journal of Radiation Oncology*Biology*Physics, 2015, 91, 1, 182

    CrossRef

  5. 5
    Thomas P. Kole, R. Charles Nichols, Song Lei, Binbin Wu, Soon N. Huh, Christopher G. Morris, Sang Lee, Michael Tong, Nancy P. Mendenhall, Anatoly Dritschilo, Sean P. Collins, A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer, Acta Oncologica, 2014, 1

    CrossRef

  6. 6
    Victor A. Macias, Manuel L. Blanco, Inmaculada Barrera, Rafael Garcia, A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity, Frontiers in Oncology, 2014, 4,

    CrossRef

  7. 7
    Constantine Mantz, A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up, Frontiers in Oncology, 2014, 4,

    CrossRef

  8. 8
    Jennifer A. Woo, Leonard N. Chen, Aditi Bhagat, Eric K. Oermann, Joy S. Kim, Rudy Moures, Thomas Yung, Siyuan Lei, Brian T. Collins, Deepak Kumar, Simeng Suy, Anatoly Dritschilo, John H. Lynch, Sean P. Collins, Clinical Characteristics and Management of Late Urinary Symptom Flare Following Stereotactic Body Radiation Therapy for Prostate Cancer, Frontiers in Oncology, 2014, 4,

    CrossRef

  9. 9
    Dong-Hoon Koh, Jin-Bum Kim, Hong-Wook Kim, Young-Seop Chang, Hyung Joon Kim, Clinical Outcomes of CyberKnife Radiotherapy in Prostate Cancer Patients: Short-term, Single-Center Experience, Korean Journal of Urology, 2014, 55, 3, 172

    CrossRef

  10. 10
    Sanjay Aneja, James B. Yu, Comparative Effectiveness Research in Radiation Oncology: Stereotactic Radiosurgery, Hypofractionation, and Brachytherapy, Seminars in Radiation Oncology, 2014, 24, 1, 35

    CrossRef

  11. 11
    Evelyn Elias, Joelle Helou, Liying Zhang, Patrick Cheung, Andrea Deabreu, Laura D’Alimonte, Perakaa Sethukavalan, Alexandre Mamedov, Marlene Cardoso, Andrew Loblaw, Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapy, Radiotherapy and Oncology, 2014, 112, 1, 83

    CrossRef

  12. 12
    Berardino De Bari, Alba Fiorentino, Stefano Arcangeli, Pierfrancesco Franco, Rolando Maria D'Angelillo, Filippo Alongi, From radiobiology to technology: what is changing in radiotherapy for prostate cancer, Expert Review of Anticancer Therapy, 2014, 14, 5, 553

    CrossRef

  13. 13
    Nina-Sophie Hegemann, Matthias Guckenberger, Claus Belka, Ute Ganswindt, Farkhad Manapov, Minglun Li, Hypofractionated radiotherapy for prostate cancer, Radiation Oncology, 2014, 9, 1

    CrossRef

  14. 14
    Fabio Ynoe de Moraes, Gabriela Moreira Silva de Siqueira, Carlos Eduardo Cintra Vita Abreu, João Luis Fernandes da Silva, Rafael Gadia, Hypofractioned radiotherapy in prostate cancer: is it the next step?, Expert Review of Anticancer Therapy, 2014, 14, 11, 1271

    CrossRef

  15. 15
    Salvina Barra, Stefano Vagge, Michela Marcenaro, Gladys Blandino, Giorgia Timon, Giulia Vidano, Dario Agnese, Marco Gusinu, Francesca Cavagnetto, Renzo Corvò, Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA, BioMed Research International, 2014, 2014, 1

    CrossRef

  16. 16
    Zaker Rana, Robyn A. Cyr, Leonard N. Chen, Brian S. Kim, Rudy A. Moures, Thomas M. Yung, Siyuan Lei, Brian T. Collins, Simeng Suy, Anatoly Dritschilo, John H. Lynch, Sean P. Collins, Improved Irritative Voiding Symptoms 3 Years after Stereotactic Body Radiation Therapy for Prostate Cancer, Frontiers in Oncology, 2014, 4,

    CrossRef

  17. 17
    Binbin Wu, Dalong Pang, Siyuan Lei, John Gatti, Michael Tong, Todd McNutt, Thomas Kole, Anatoly Dritschilo, Sean Collins, Improved robotic stereotactic body radiation therapy plan quality and planning efficacy for organ-confined prostate cancer utilizing overlap-volume histogram-driven planning methodology, Radiotherapy and Oncology, 2014, 112, 2, 221

    CrossRef

  18. 18
    V. A. Macias, M. L. Blanco, L. A. Perez-Romasanta, Initial experience with stereotactic body radiation therapy for localized prostate cancer using helical tomotherapy, Clinical and Translational Oncology, 2014, 16, 4, 380

    CrossRef

  19. 19
    Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, Timothy N Showalter, Robert B Den, Is robotic arm stereotactic body radiation therapy ‘virtual high-dose rate brachytherapy’ for prostate cancer? An analysis of comparative effectiveness using published data, Expert Review of Medical Devices, 2014, 1

    CrossRef

  20. 20
    Onita Bhattasali, Leonard N Chen, Jennifer Woo, Jee-Won Park, Joy S Kim, Rudy Moures, Thomas Yung, Siyuan Lei, Brian T Collins, Keith Kowalczyk, Simeng Suy, Anatoly Dritschilo, John H Lynch, Sean P Collins, Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer, Radiation Oncology, 2014, 9, 1, 52

    CrossRef

  21. 21
    Daniel Y Joh, Leonard N Chen, Gerald Porter, Aditi Bhagat, Sumit Sood, Joy S Kim, Rudy Moures, Thomas Yung, Siyuan Lei, Brian T Collins, Andrew W Ju, Simeng Suy, John Carroll, John H Lynch, Anatoly Dritschilo, Sean P Collins, Proctitis following stereotactic body radiation therapy for prostate cancer, Radiation Oncology, 2014, 9, 1

    CrossRef

  22. You have free access to this content22
    Neil E. Martin, Anthony V. D'Amico, Progress and controversies: Radiation therapy for prostate cancer, CA: A Cancer Journal for Clinicians, 2014, 64, 6
  23. 23
    Thomas P. Kole, Leonard N. Chen, Olusola Obayomi-Davies, Joy S. Kim, Siyuan Lei, Simeng Suy, Anatoly Dritschilo, Sean P. Collins, Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer, Acta Oncologica, 2014, 1

    CrossRef

  24. 24
    Alan Jay Katz, Josephine Kang, Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study, Frontiers in Oncology, 2014, 4,

    CrossRef

  25. 25
    L. Quero, C. Hennequin, Radiothérapie stéréotaxique des cancers de la prostate, Cancer/Radiothérapie, 2014, 18, 4, 332

    CrossRef

  26. 26
    Filippo Alongi, Alba Fiorentino, Berardino De Bari, SBRT and extreme hypofractionation: A new era in prostate cancer treatments?, Reports of Practical Oncology & Radiotherapy, 2014,

    CrossRef

  27. 27
    Einsley Janowski, Leonard N Chen, Joy S Kim, Siyuan Lei, Simeng Suy, Brian Collins, John Lynch, Anatoly Dritschilo, Sean Collins, Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm3), Radiation Oncology, 2014, 9, 1

    CrossRef

  28. 28
    Patrick Kupelian, Niraj H. Mehta, Chris King, Michael Steinberg, Steven E. Finkelstein, Eduardo Fernandez, Stereotactic body radiation therapy for prostate cancer: Rational and reasonable, Practical Radiation Oncology, 2014,

    CrossRef

  29. 29
    D. W. Nathan Kim, Christopher Straka, L. Chinsoo Cho, Robert D. Timmerman, Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study, Frontiers in Oncology, 2014, 4,

    CrossRef

  30. 30
    Alan Jay Katz, Josephine Kang, Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study, Frontiers in Oncology, 2014, 4,

    CrossRef

  31. You have free access to this content31
    Tze-Jian Tan, Shankar Siva, Farshad Foroudi, Suki Gill, Stereotactic body radiotherapy for primary prostate cancer: A systematic review, Journal of Medical Imaging and Radiation Oncology, 2014, 58, 5
  32. 32
    Yun Hee Lee, Seok Hyun Son, Sei Chul Yoon, Mina Yu, Byung Ock Choi, Yeon Sil Kim, Hong Seok Jang, Sang Nam Lee, Ji Sun Jang, Tae Kon Hwang, Stereotactic body radiotherapy for prostate cancer: A preliminary report, Asia-Pacific Journal of Clinical Oncology, 2014, 10, 2
  33. 33
    Y. Manabe, Y. Shibamoto, C. Sugie, F. Baba, S. Ayakawa, A. Nagai, S. Takemoto, A. Hayashi, N. Kawai, M. Takeuchi, S. Ishikura, K. Kohri, T. Yanagi, Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer, Journal of Radiation Research, 2014, 55, 3, 494

    CrossRef

  34. 34
    Sean P. Collins, Simeng Suy, Leonard N. Chen, Brian T. Collins, Anatoly Dritschilo, A Response to Sher et al, “Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer”, American Journal of Clinical Oncology, 2013, 36, 3, 316

    CrossRef

  35. 35
    Giampaolo Bolzicco, Maria Favretto, Ninfa Satariano, Enrico Scremin, Carmelo Tambone, Andrea Tasca, A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy, BMC Urology, 2013, 13, 1, 49

    CrossRef

  36. 36
    Thomas Seisen, Sarah J. Drouin, Véronique Phé, Jérome Parra, Pierre Mozer, Marc-Olivier Bitker, Olivier Cussenot, Morgan Rouprêt, Current role of image-guided robotic radiosurgery (Cyberknife®) for prostate cancer treatment, BJU International, 2013, 111, 5
  37. 37
    Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den, Evolution of advanced technologies in prostate cancer radiotherapy, Nature Reviews Urology, 2013, 10, 10, 565

    CrossRef

  38. 38
    Christopher R. King, Sean Collins, Donald Fuller, Pin-Chieh Wang, Patrick Kupelian, Michael Steinberg, Alan Katz, Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials, International Journal of Radiation Oncology*Biology*Physics, 2013, 87, 5, 939

    CrossRef

  39. 39
    L. Chinsoo Cho, Robert Timmerman, Brian Kavanagh, Hypofractionated External-Beam Radiotherapy for Prostate Cancer, Prostate Cancer, 2013, 2013, 1

    CrossRef

  40. 40
    Andrew W Ju, Hongkun Wang, Eric K Oermann, Benjamin A Sherer, Sunghae Uhm, Viola J Chen, Arjun V Pendharkar, Heather N Hanscom, Joy S Kim, Siyuan Lei, Simeng Suy, John H Lynch, Anatoly Dritschilo, Sean P Collins, Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer, Radiation Oncology, 2013, 8, 1, 30

    CrossRef

  41. 41
    Alvin R. Cabrera, W. Robert Lee, Hypofractionation for Clinically Localized Prostate Cancer, Seminars in Radiation Oncology, 2013, 23, 3, 191

    CrossRef

  42. 42
    Filippo Alongi, Luca Cozzi, Stefano Arcangeli, Cristina Iftode, Tiziana Comito, Elisa Villa, Francesca Lobefalo, Pierina Navarria, Giacomo Reggiori, Pietro Mancosu, Elena Clerici, Antonella Fogliata, Stefano Tomatis, Gianluigi Taverna, Pierpaolo Graziotti, Marta Scorsetti, Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study, Radiation Oncology, 2013, 8, 1, 171

    CrossRef

  43. 43
    Ayal A. Aizer, Jonathan J. Paly, Jason A. Efstathiou, Multidisciplinary Care and Management Selection in Prostate Cancer, Seminars in Radiation Oncology, 2013, 23, 3, 157

    CrossRef

  44. 44
    Olusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, Henry C Wright, Sunghae Uhm, Joy S Kim, Thomas M Yung, Siyuan Lei, Gerald P Batipps, John Pahira, Kevin G McGeagh, Brian T Collins, Keith Kowalczyk, Gaurav Bandi, Deepak Kumar, Simeng Suy, Anatoly Dritschilo, John H Lynch, Sean P Collins, Potency preservation following stereotactic body radiation therapy for prostate cancer, Radiation Oncology, 2013, 8, 1, 256

    CrossRef

  45. 45
    Caspian Oliai, Rachelle Lanciano, Brian Sprandio, Jun Yang, John Lamond, Steven Arrigo, Michael Good, Michael Mooreville, Bruce Garber, Luther W. Brady, Stereotactic body radiation therapy for the primary treatment of localized prostate cancer, Journal of Radiation Oncology, 2013, 2, 1, 63

    CrossRef

  46. 46
    Alan J Katz, Michael Santoro, Fred Diblasio, Richard Ashley, Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years, Radiation Oncology, 2013, 8, 1, 118

    CrossRef

  47. 47
    Christopher R. King, Debra Freeman, Irving Kaplan, Donald Fuller, Giampaolo Bolzicco, Sean Collins, Robert Meier, Jason Wang, Patrick Kupelian, Michael Steinberg, Alan Katz, Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials, Radiotherapy and Oncology, 2013, 109, 2, 217

    CrossRef

  48. 48
    Nicholas G. Zaorsky, Nitin Ohri, Timothy N. Showalter, Adam P. Dicker, Robert B. Den, Systematic review of hypofractionated radiation therapy for prostate cancer, Cancer Treatment Reviews, 2013, 39, 7, 728

    CrossRef

  49. 49
    Y. Yoshioka, K. Yoshida, H. Yamazaki, N. Nonomura, K. Ogawa, The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer, Journal of Radiation Research, 2013, 54, 5, 781

    CrossRef